BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8357941)

  • 1. The use of liquid chromatography-mass spectrometry for the identification and quantification of urinary iminodipeptides in prolidase deficiency.
    Sugahara K; Ohno T; Arata J; Kodama H
    Eur J Clin Chem Clin Biochem; 1993 May; 31(5):317-22. PubMed ID: 8357941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid chromatography-mass spectrometry for the qualitative analyses of iminodipeptides in the urine of patients with prolidase deficiency.
    Kodama H; Nakamura H; Sugahara K; Numajiri Y
    J Chromatogr; 1990 May; 527(2):279-88. PubMed ID: 2387877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of iminodipeptides in the serum of patients with prolidase deficiency using liquid chromatography-mass spectrometry.
    Sugahara K; Jianying Z; Yamamoto Y; Yasuda K; Kodama H; Kodama H
    Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):113-7. PubMed ID: 8031960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid chromatography-mass spectrometry for simultaneous analyses of iminodipeptides containing an N-terminal or a C-terminal proline.
    Sugahara K; Kodama H
    J Chromatogr; 1991 Apr; 565(1-2):408-15. PubMed ID: 1874885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolidase deficiency: a patient without hydroxyproline-containing iminodipeptides in urine.
    Wysocki SJ; Hahnel R; Mahoney T; Wilson RG; Panegyres PK
    J Inherit Metab Dis; 1988; 11(2):161-5. PubMed ID: 3139928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of serum iminodipeptides and prednisolone on superoxide generation and tyrosyl phosphorylation of proteins in neutrophils from a patient with prolidase deficiency.
    Zhang J; Sugahara K; Yasuda K; Kodama H; Sagara Y; Kodama H
    Free Radic Biol Med; 1998 Mar; 24(5):689-98. PubMed ID: 9586797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of amino acids and its metabolites on prolidase activity against various iminodipeptides in erythrocytes from normal human and a patient with prolidase deficiency.
    Liu G; Nakayama K; Awata S; Wang W; Yamashita K; Manabe M; Kodama H
    Clin Chim Acta; 2004 Dec; 350(1-2):211-7. PubMed ID: 15530480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolidase deficiency in cultured human fibroblasts: biochemical pathology and iminodipeptide-enhanced growth.
    Dolenga M; Hechtman P
    Pediatr Res; 1992 Oct; 32(4):479-82. PubMed ID: 1437403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iminodipeptiduria: a genetic defect in recycling collagen; a method for determining prolidase in erythrocytes.
    Jackson SH; Dennis AW; Greenberg M
    Can Med Assoc J; 1975 Oct; 113(8):759, 762-3. PubMed ID: 803128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolidase deficiency: biochemical study of erythrocyte and skin fibroblast prolidase activity in Italian patients.
    Zanaboni G; Dyne KM; Rossi A; Monafo V; Cetta G
    Haematologica; 1994; 79(1):13-8. PubMed ID: 15378943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolidase deficiency diagnosed by 1H NMR spectroscopy of urine.
    Moolenaar SH; Engelke UF; Abeling NG; Mandel H; Duran M; Wevers RA
    J Inherit Metab Dis; 2001 Dec; 24(8):843-50. PubMed ID: 11916317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of prolinase against various iminodipeptides in erythrocyte lysates from a normal human and a patient with prolidase deficiency.
    Wang W; Liu G; Yamashita K; Manabe M; Kodama H
    Clin Chem Lab Med; 2004; 42(10):1102-8. PubMed ID: 15552267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of prolidase activity in erythrocytes from a patient with prolidase deficiency: comparison with prolidase I and II purified from normal human erythrocytes.
    Liu G; Nakayama K; Sagara Y; Awata S; Yamashita K; Manabe M; Kodama H
    Clin Biochem; 2005 Jul; 38(7):625-31. PubMed ID: 16009141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of capillary zone electrophoresis for analysis of imidodipeptides in urine of prolidase-deficient patients.
    Zanaboni G; Grimm R; Dyne KM; Rossi A; Cetta G; Iadarola P
    J Chromatogr B Biomed Appl; 1996 Aug; 683(1):97-107. PubMed ID: 8876444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolidase and prolidase deficiency.
    Myara I; Charpentier C; Lemonnier A
    Life Sci; 1984 May; 34(21):1985-98. PubMed ID: 6727550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolidase deficiency with imidodipeptiduria. A familial case with and without clinical symptoms.
    Isemura M; Hanyu T; Gejyo F; Nakazawa R; Igarashi R; Matsuo S; Ikeda K; Sato Y
    Clin Chim Acta; 1979 May; 93(3):401-7. PubMed ID: 445856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood transfusions in the therapy of a case of prolidase deficiency.
    Berardesca E; Fideli D; Bellosta M; Dyne KM; Zanaboni G; Cetta G
    Br J Dermatol; 1992 Feb; 126(2):193-5. PubMed ID: 1536787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations.
    Lupi A; Tenni R; Rossi A; Cetta G; Forlino A
    Amino Acids; 2008 Nov; 35(4):739-52. PubMed ID: 18340504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for prolidase deficiency disease mechanisms.
    Wilk P; Uehlein M; Piwowarczyk R; Dobbek H; Mueller U; Weiss MS
    FEBS J; 2018 Sep; 285(18):3422-3441. PubMed ID: 30066404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly sensitive determination of N-terminal prolyl dipeptides, proline and hydroxyproline in urine by high-performance liquid chromatography using a new fluorescent labelling reagent, 4-(5,6-dimethoxy-2-phthalimidinyl)-2-methoxyphenylsulfonyl chloride.
    Inoue H; Iguchi H; Kono A; Tsuruta Y
    J Chromatogr B Biomed Sci Appl; 1999 Mar; 724(2):221-30. PubMed ID: 10219662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.